Overview and Scop
Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.
Sizing and Forecast
The influenza diagnostic market size has grown strongly in recent years. It will grow from <b>$2.59 billion in 2023 to $2.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. </b> The growth in the historic period can be attributed to public health concerns, technological advancements, antiviral medications, pandemic preparedness.
The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to <b>$3.68 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. </b> The growth in the forecast period can be attributed to continuing seasonal influenza, point-of-care testing, remote and home testing, digital health integration. Major trends in the forecast period include point-of-care testing, molecular diagnostics, antigen-based tests, multiplex assays, automation and robotics.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report
Segmentation & Regional Insights
The influenza diagnostic market covered in this report is segmented –
1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
<b>North America</b> was the largest region in the influenza diagnostics market in 2023. <b>Western Europe</b> was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp
Major Driver Impacting Market Growth
Rapid diagnostic tests are expected to propel the growth of the influenza diagnostic market going forward. Diagnostic tests are medical procedures or tools used to confirm or rule out a condition or disease. Rapid influenza diagnostic tests (RIDTs) can detect influenza viral antigens in 10-15 minutes with moderate sensitivity (50-70%). For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, during September 2020 to May 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for an influenza virus. Thus, rapid diagnostic tests are driving the growth of the influenza diagnostic market.
Key Industry Players
Major companies operating in the influenza diagnostic market include <b>F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.</b>
The influenza diagnostic market report table of contents includes:
1. Executive Summary
2. Influenza Diagnostic Market Characteristics
3. Influenza Diagnostic Market Trends And Strategies
4. Influenza Diagnostic Market – Macro Economic Scenario
5. Global Influenza Diagnostic Market Size and Growth
.
.
.
26. South America Influenza Diagnostic Market
27. Brazil Influenza Diagnostic Market
28. Middle East Influenza Diagnostic Market
29. Africa Influenza Diagnostic Market
30. Influenza Diagnostic Market Competitive Landscape And Company Profiles
Top Major Players:
- Hoffmann-La Roche Ltd
- Quidel Corporation
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Hologic Inc
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
